PGIIX | RNPHX | PGIIX / RNPHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 9 years | - |
Gain YTD | 7.143 | 12.396 | 58% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 250 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 425M | 137B | 0% |
Annual Yield % from dividends | 0.00 | 1.00 | - |
Returns for 1 year | 13.05 | 15.05 | 87% |
Returns for 3 years | -6.88 | -9.61 | 72% |
Returns for 5 years | 45.67 | 41.21 | 111% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TIQIX | 27.28 | 0.11 | +0.40% |
Touchstone Non-US ESG Equity Y | |||
FFIMX | 20.85 | N/A | N/A |
Fidelity Advisor Asset Manager 50% I | |||
IEMLX | 10.11 | N/A | N/A |
Voya Multi-Manager Emerging Markets Eq W | |||
FVLTX | 23.38 | -0.18 | -0.76% |
Fidelity Advisor Value Leaders M | |||
FPHAX | 30.32 | -0.59 | -1.91% |
Fidelity Select Pharmaceuticals Port |